Jazz Pharmaceuticals plc — Director's Dealing 2016

Nov 15, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-11-11

Reporting Person: O'Keefe Kenneth W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-11	Ordinary Shares	P	1200.0	$114.3047	Acquired	1200	Indirect
2016-11-11	Ordinary Shares	P	300.0	$114.33	Acquired	1500	Indirect
2016-11-14	Ordinary Shares	P	500.0	$112.447	Acquired	2000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	12107	Direct

Footnotes

F1: Shares were acquired for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.

F2: Reflects purchases of ordinary shares executed in multiple transactions at prices ranging from $112.4000 to $112.4588. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were made.